Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
- 15 December 1993
- Vol. 72 (S12) , 3888-3895
- https://doi.org/10.1002/1097-0142(19931215)72:12+<3888::aid-cncr2820721726>3.0.co;2-b
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancerEuropean Journal Of Cancer, 1993
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized TrialJournal of Urology, 1993
- Complete androgen blockade in prostate cancer: An overview of randomized trialsThe Prostate, 1992
- A Multicenter Randomized Trial Comparing the Luteinizing Hormone-Releasing Hormone Analogue Goserelin Acetate Alone and with Flutamide in the Treatment of Advanced Prostate CancerJournal of Urology, 1991
- Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic CarcinomaBritish Journal of Urology, 1991
- ConclusionsCancer, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Criteria for Evaluating Patient Responses to Treatment Modalities for Prostatic CancerUrologic Clinics of North America, 1984
- Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II TumoursPublished by Springer Nature ,1980